News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research Report>Macquarie Slashes WUXI BIO TP by 63% to $14 on 2024 Guidance Cut, Persistent Geopolitical Risk
WUXI BIO (02269.HK)'s 2023 revenue increased by 12% YoY to RMB17 billion, Macquarie released a research report saying. Adjusted earnings dropped by 5% YoY to RMB4.7 billion, in...
Reset
Send
The window will close in 5 seconds
<Research Report>Macquarie Slashes WUXI BIO TP by 63% to $14 on 2024 Guidance Cut, Persistent Geopolitical Risk
Close
Recommend
16
Positive
26
Negative
15
 
SHORT SELL
 
STOCK INFO

WUXI BIO (02269.HK)  -0.080 (-0.569%)    Short selling $29.76M; Ratio 2.631%   's 2023 revenue increased by 12% YoY to RMB17 billion, Macquarie released a research report saying. Adjusted earnings dropped by 5% YoY to RMB4.7 billion, in line with the market's expectation and the guidance in December 2023.

It would be difficult to win orders for CMO projects again, due to the ongoing geopolitical risks, and the Company lowered its revenue and net profit guidance for 2024, Macquarie quoted WUXI BIO's management as saying.

Related NewsJefferies Trims WUXI BIO (02269.HK) TP to $42, Rating Buy
Accordingly, Macquarie lowered its revenue forecasts for 2024 to 2026 by 6%/ 18%/ 21% each, and its earnings forecasts by 10%/ 24%/ 25%, respectively.

Macquarie kept rating at Neutral, and slashed its target price by 63% to $14, from $38, which is equivalent to PE ratio forecasts of 12x/ 10x for 2024/ 2025, respectively.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-05-17 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.